215 related articles for article (PubMed ID: 16887163)
1. Effects of human TRIM5alpha polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection.
Javanbakht H; An P; Gold B; Petersen DC; O'Huigin C; Nelson GW; O'Brien SJ; Kirk GD; Detels R; Buchbinder S; Donfield S; Shulenin S; Song B; Perron MJ; Stremlau M; Sodroski J; Dean M; Winkler C
Virology; 2006 Oct; 354(1):15-27. PubMed ID: 16887163
[TBL] [Abstract][Full Text] [Related]
2. Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection.
Speelmon EC; Livingston-Rosanoff D; Li SS; Vu Q; Bui J; Geraghty DE; Zhao LP; McElrath MJ
J Virol; 2006 Mar; 80(5):2463-71. PubMed ID: 16474153
[TBL] [Abstract][Full Text] [Related]
3. The effect of Trim5 polymorphisms on the clinical course of HIV-1 infection.
van Manen D; Rits MA; Beugeling C; van Dort K; Schuitemaker H; Kootstra NA
PLoS Pathog; 2008 Feb; 4(2):e18. PubMed ID: 18248091
[TBL] [Abstract][Full Text] [Related]
4. A TRIM5alpha exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort.
Price H; Lacap P; Tuff J; Wachihi C; Kimani J; Ball TB; Luo M; Plummer FA
AIDS; 2010 Jul; 24(12):1813-21. PubMed ID: 20588169
[TBL] [Abstract][Full Text] [Related]
5. Impact of novel TRIM5alpha variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection.
Nakajima T; Nakayama EE; Kaur G; Terunuma H; Mimaya JI; Ohtani H; Mehra N; Shioda T; Kimura A
AIDS; 2009 Oct; 23(16):2091-100. PubMed ID: 19710594
[TBL] [Abstract][Full Text] [Related]
6. TRIM5 gene polymorphisms in HIV-1-infected patients and healthy controls from Northeastern Brazil.
Celerino da Silva R; Coelho AV; Arraes LC; Brandão LA; Crovella S; Guimarães RL
Immunol Res; 2016 Dec; 64(5-6):1237-1242. PubMed ID: 27388872
[TBL] [Abstract][Full Text] [Related]
7. A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies.
Torimiro JN; Javanbakht H; Diaz-Griffero F; Kim J; Carr JK; Carrington M; Sawitzke J; Burke DS; Wolfe ND; Dean M; Sodroski J
Virology; 2009 Aug; 391(1):140-7. PubMed ID: 19577266
[TBL] [Abstract][Full Text] [Related]
8. A naturally occurring single amino acid substitution in human TRIM5α linker region affects its anti-HIV type 1 activity and susceptibility to HIV type 1 infection.
Nakayama EE; Nakajima T; Kaur G; Mimaya JI; Terunuma H; Mehra N; Kimura A; Shioda T
AIDS Res Hum Retroviruses; 2013 Jun; 29(6):919-24. PubMed ID: 23379364
[TBL] [Abstract][Full Text] [Related]
9. Wild type and H43Y variant of human TRIM5alpha show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro.
Nakayama EE; Carpentier W; Costagliola D; Shioda T; Iwamoto A; Debre P; Yoshimura K; Autran B; Matsushita S; Theodorou I
Immunogenetics; 2007 Jun; 59(6):511-5. PubMed ID: 17406861
[TBL] [Abstract][Full Text] [Related]
10. An HIV-1 resistance polymorphism in TRIM5α gene among Chinese intravenous drug users.
Liu FL; Qiu YQ; Li H; Kuang YQ; Tang X; Cao G; Tang NL; Zheng YT
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):306-11. PubMed ID: 21107267
[TBL] [Abstract][Full Text] [Related]
11. Role of common human TRIM5alpha variants in HIV-1 disease progression.
Goldschmidt V; Bleiber G; May M; Martinez R; Ortiz M; Telenti A;
Retrovirology; 2006 Aug; 3():54. PubMed ID: 16925802
[TBL] [Abstract][Full Text] [Related]
12. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
Keckesova Z; Ylinen LM; Towers GJ
J Virol; 2006 May; 80(10):4683-90. PubMed ID: 16641261
[TBL] [Abstract][Full Text] [Related]
13. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.
Yap MW; Nisole S; Stoye JP
Curr Biol; 2005 Jan; 15(1):73-8. PubMed ID: 15649369
[TBL] [Abstract][Full Text] [Related]
14. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.
Song B; Javanbakht H; Perron M; Park DH; Stremlau M; Sodroski J
J Virol; 2005 Apr; 79(7):3930-7. PubMed ID: 15767395
[TBL] [Abstract][Full Text] [Related]
15. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J
J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307
[TBL] [Abstract][Full Text] [Related]
16. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
Sastri J; Campbell EM
AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
[TBL] [Abstract][Full Text] [Related]
17. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
Diaz-Griffero F; Perron M; McGee-Estrada K; Hanna R; Maillard PV; Trono D; Sodroski J
Virology; 2008 Sep; 378(2):233-42. PubMed ID: 18586294
[TBL] [Abstract][Full Text] [Related]
18. Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
Yap MW; Nisole S; Lynch C; Stoye JP
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10786-91. PubMed ID: 15249690
[TBL] [Abstract][Full Text] [Related]
19. Immunoproteasome activation enables human TRIM5α restriction of HIV-1.
Jimenez-Guardeño JM; Apolonia L; Betancor G; Malim MH
Nat Microbiol; 2019 Jun; 4(6):933-940. PubMed ID: 30886358
[TBL] [Abstract][Full Text] [Related]
20. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
Stremlau M; Perron M; Welikala S; Sodroski J
J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
